Literature DB >> 9466575

Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar.

P Schmid1, P Itin, G Cherry, C Bi, D A Cox.   

Abstract

In the present study we have analyzed and compared, by immunohistochemistry and in situ hybridization, the expression pattern of the R4/ALK5 transforming growth factor (TGF)-beta type I receptor (RI) and the TGF-beta type II receptor (RII) in normal human skin, in wounded skin at various stages during the transition of wound granulation tissue to scar, and in long-persisting post-burn hypertrophic scars. In normal human skin, expression of RI and RII was clearly visible in the epidermis, in epidermal appendages, and in vascular cells, although only a small number of dermal fibroblasts revealed detectable levels of TGF-beta receptor expression. In contrast, granulation tissue fibroblasts showed strong expression of both TGF-beta receptor types, although in normal-healing excisional wounds their density decreased during granulation tissue remodeling. However, in post-burn hypertrophic scars, RI- and RII-overexpressing fibroblasts were found in high densities up to 20 months after injury. From these findings we suggest that the repair process of deep wounds involves the transformation of a subset of fibroblastic cells toward an increased TGF-beta responsiveness and a transient accumulation of these cells at the wound site. In addition, our study provides evidence that excessive scarring is associated with a failure to eliminate TGF-beta receptor-overexpressing fibroblasts during granulation tissue remodeling, which leads to a persistent autocrine, positive feedback loop that results in over-production of matrix proteins and subsequent fibrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466575      PMCID: PMC1857945     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model.

Authors:  D Quaglino; L B Nanney; R Kennedy; J M Davidson
Journal:  Lab Invest       Date:  1990-09       Impact factor: 5.662

Review 3.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

Authors:  A B Roberts; M B Sporn
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

4.  Histologic basis of keloid and hypertrophic scar differentiation. Clinicopathologic correlation.

Authors:  W R Blackburn; B Cosman
Journal:  Arch Pathol       Date:  1966-07

5.  Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts.

Authors:  A McWhirter; P Colosetti; K Rubin; K Miyazono; C Black
Journal:  Lab Invest       Date:  1994-12       Impact factor: 5.662

6.  Injury induced expression of TGF-beta 1 mRNA is enhanced by exogenously applied TGF-beta S.

Authors:  P Schmid; S Kunz; N Cerletti; G McMaster; D Cox
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

7.  Immunohistochemical localization of growth factors in fetal wound healing.

Authors:  D J Whitby; M W Ferguson
Journal:  Dev Biol       Date:  1991-09       Impact factor: 3.582

8.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Authors:  E Van Obberghen-Schilling; N S Roche; K C Flanders; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

9.  The extracellular matrix of lip wounds in fetal, neonatal and adult mice.

Authors:  D J Whitby; M W Ferguson
Journal:  Development       Date:  1991-06       Impact factor: 6.868

10.  GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.

Authors:  R Wieser; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  46 in total

1.  Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Authors:  Kathleen C Flanders; Christopher D Major; Alidad Arabshahi; Ekinadese E Aburime; Miya H Okada; Makiko Fujii; Timothy D Blalock; Gregory S Schultz; Anastasia Sowers; Mario A Anzano; James B Mitchell; Angelo Russo; Anita B Roberts
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 3.  Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.

Authors:  Casimiro Gerarduzzi; John A Di Battista
Journal:  Inflamm Res       Date:  2016-12-31       Impact factor: 4.575

4.  Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan).

Authors:  Kuniaki Nakanishi; Maki Uenoyama; Naruya Tomita; Ryuichi Morishita; Yasufumi Kaneda; Toshio Ogihara; Kunio Matsumoto; Toshikazu Nakamura; Akie Maruta; Shigeo Matsuyama; Toshiaki Kawai; Takashi Aurues; Takuya Hayashi; Tomosumi Ikeda
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.

Authors:  Nicholas A Mignemi; Doha M Itani; John H Fasig; Vicki L Keedy; Kenneth R Hande; Brent W Whited; Kelly C Homlar; Hernan Correa; Cheryl M Coffin; Jennifer O Black; Yajun Yi; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Jonathan G Schoenecker; Justin M M Cates
Journal:  Cancer Sci       Date:  2012-11-15       Impact factor: 6.716

6.  Attenuation of Abnormal Scarring Using Spherical Nucleic Acids Targeting Transforming Growth Factor Beta 1.

Authors:  Adam Ponedal; Shengshuang Zhu; Anthony J Sprangers; Xiao-Qi Wang; David C Yeo; Daniel C S Lio; Mengjia Zheng; Matthew Capek; Suguna P Narayan; Brian Meckes; Amy S Paller; Chenjie Xu; Chad A Mirkin
Journal:  ACS Appl Bio Mater       Date:  2020-11-13

Review 7.  Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions.

Authors:  Clement D Marshall; Michael S Hu; Tripp Leavitt; Leandra A Barnes; H Peter Lorenz; Michael T Longaker
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-02-01       Impact factor: 4.730

Review 8.  The Role of Hypoxia-Inducible Factor in Wound Healing.

Authors:  Wan Xing Hong; Michael S Hu; Mikaela Esquivel; Grace Y Liang; Robert C Rennert; Adrian McArdle; Kevin J Paik; Dominik Duscher; Geoffrey C Gurtner; H Peter Lorenz; Michael T Longaker
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-05-01       Impact factor: 4.730

9.  Serum Levels of TGF-beta1, TIMP-1 and TIMP-2 in Patients with Lumbar Spinal Stenosis and Disc Herniation.

Authors:  Hyung-Jun Kim; Jong-Beom Park; Ho-Yeon Won; Han Chang
Journal:  Asian Spine J       Date:  2007-06-30

10.  Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells.

Authors:  Igor Bryukhovetskiy; Valeriy Shevchenko
Journal:  Oncol Lett       Date:  2016-06-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.